• Trima Accel® Collection System
  • How it Works
  • Automation Benefits
  • Accessories
  • User Materials
• Spectra Optia® Apheresis System
• COBE® Spectra Apheresis System
• Vista® Information System
• Elutra® Cell Separation System
• Atreus® Whole Blood Processing System
• OrbiSac® System
• Mirasol® Pathogen Reduction Technology
• COBE® 2991 Cell Processor
• Accessories & Supplies

Automation Benefits

The Trima Accel Collection System automation reduces risks for patients

Blood safety requirements already help you to limit the risks associated with blood transfusions. Reducing risks to patients happens through blood testing and deferrals. You can also reduce patient exposure simply by switching from whole blood donations to automated donations with your Trima Accel Collection System equipment.

Remember, the Trima Accel Collection System lets you collect combinations of blood products — plasma, platelets and red blood cells. By collecting multiples of specific components needed by patients, you collect the blood products needed from a smaller donor pool. That translates into reduced risks for high-risk patients. They simply get exposed to fewer donors.

The Trima Accel Collection System helps reduce donor exposure dramatically, especially for transfusions of platelets. Look at these patient examples:

Leukemia patient

Needed transfusions: 6 – 8 platelet transfusions per week for 2 – 4 weeks
Donor exposure with whole blood: up to 40 donors for platelets
Donor exposure with the Trima Accel Collection System: 2 – 4 donors for platelets

Patient receiving a bone marrow transplant

Needed transfusions: 20 platelets and 20 red cells
Donor exposure with whole blood: 120 donors for platelets, 20 donors for red cells
Donor exposure with the Trima Accel Collection System: 10 – 20 donors for platelets, 10 – 20 donors for red cells

Find out how CaridianBCT can help you implement a donor conversion program to move your whole blood donors to component donors instead.

[ Feedback ]